Sanctuary Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Sanctuary Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.85M	Sell	14,486 -454	-3%	-$56.7K	0.01%	991
2025 Q4	$1.82M	Buy	14,940 +3,227	+28%	+$370K	0.01%	983
2025 Q3	$1.17M	Sell	11,713 -1,377	-11%	-$124K	0.01%	1196
2025 Q2	$1.09M	Sell	13,090 -1,237	-9%	-$98.7K	0.01%	1169
2025 Q1	$1.16M	Sell	14,327 -845	-6%	-$75.5K	0.01%	1062
2024 Q4	$1.42M	Buy	15,172 +6	+0%	+$581	0.01%	1053
2024 Q3	$1.46M	Buy	15,166 +1,711	+13%	+$168K	0.01%	1059
2024 Q2	$1.12M	Buy	+13,455	New	+$1.21M	0.01%	1131

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Sanctuary Advisors's XBI Position: Q1 2026 in Review

Sanctuary Advisors reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 3% in Q1 2026, selling an estimated $56.7K and leaving 14,486 shares worth $1.85M. The position accounts for 0.01% of the portfolio, ranked #991.

Sanctuary Advisors first reported a position in XBI in Q2 2024 and has held it in 8 quarters since. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Sanctuary Advisors held 14,486 shares of State Street SPDR S&P Biotech ETF worth $1.85M as of Q1 2026.
Sanctuary Advisors sold 454 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $56.7K.
State Street SPDR S&P Biotech ETF made up 0.01% of Sanctuary Advisors's portfolio in Q1 2026, its #991 holding.
Sanctuary Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q2 2024 and has held it in 8 quarters since.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Sanctuary Advisors's 13F filing for Q1 2026, filed 5 May 2026.